Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants

See also
Status	Clinical Trial	Phase
Completed	`NCT01354795` - Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic Mass	N/A
Completed	`NCT00958841` - Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin	Phase 2
Terminated	`NCT00249301` - A Study of MLN8054 in Patients With Advanced Solid Tumors	Phase 1
Recruiting	`NCT06122896` - Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals	Early Phase 1
Terminated	`NCT02602067` - 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients	Phase 1
Recruiting	`NCT06411795` - Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy	Phase 2
Completed	`NCT03622229` - EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle	N/A
Recruiting	`NCT06400472` - A Study of LY4170156 in Participants With Selected Advanced Solid Tumors	Phase 1
Completed	`NCT02791503` - CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy	N/A
Recruiting	`NCT05786716` - DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations	Phase 2/Phase 3
Completed	`NCT03322592` - EUS-FNB With ROSE Vs. EUS-FNB Without ROSE	N/A
Completed	`NCT05745415` - Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer
Recruiting	`NCT05083247` - Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma	Phase 2
Completed	`NCT00436423` - A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer	Phase 2
Completed	`NCT02900950` - Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer	N/A
Completed	`NCT00711191` - A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas	Phase 1
Completed	`NCT00222898` - Cancer Detection in Pancreatic Cysts	N/A
Completed	`NCT00034281` - Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2	Phase 1
Completed	`NCT00005926` - Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas	Phase 2
Recruiting	`NCT04164017` - Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions	N/A

NCT number	NCT00267020
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 2
Start date	December 2005
Completion date	May 2008

Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms